$24.95 per bottle (120 capsules) plus s&h (state tax will be added for California residents)
 
 
           Special Offer
Buy 3 bottles of OncoGuard and receive the 4th bottle for free!  Click the order button below to take advantage of this special offer.

 
About Us
Health, Cancer, Cancer Prevention, Oncology Prevention, Diet, Lifestyle, Nutrition, Green Tea, Vitamin D, Broccoli, Pomegranate, Resveratrol, OncoguardDominique T. Nguyen, Ph.D.  
CEO

Dr. Nguyen received her Ph.D. in Molecular Pharmacology and Toxicology from the University of Southern California (USC) School of Pharmacy. While at USC, Dr. Nguyen’s research focus was in the area of phytoestrogens and isoflavones as potential cancer prevention agents. Dr. Nguyen has over ten years of research experience in both the academic and biotechnology sectors, including drug discovery and drug development.



Selected Abstracts & Publications by Dr. Nguyen:

Nguyen D.T., Hernandez E., Vauzour D., Schonthal A.H., Rice-Evans C. , Cadenas E. and Spencer J.P.E.  The intracellular genistein metabolite 5,7,3¢,4¢-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in breast cancer cells via modulation of p38 signaling pathway Free Rad Biol & Med  15;41, 2006.:1225-39

Spencer J.P.E, Nguyen D.T., and Vasour D. Flavanoid regulation of cell cycle via interactions of MAP kinase and PI3 kinase/AKT kinase Oxidants and antioxidants in biology, Oxygen Club of California , 2006

Nguyen D.T., Garcia J.V., and Cadenas E. Genistein causes cell cycle arrest and apoptosis in T47D breast cancer cells.  Oxidants and antioxidants in biology, Oxygen Club of California, 2002.

Nguyen D.T., Garcia J.V., and Cadenas E. Genistein causes cell cycle arrest in T47D breast cancer cells.  Free Radical Biology & Medicine, 2001.

Nguyen D.T.,
Garcia J.V., and Cadenas E. Genistein causes cell cycle arrest via inhibiton of p53-independent mechanisms in T47D breast cancer cells.  Free Radical Biology and Medicine, 2000.
 
 

Green Tea Extract, Breast Cancer, Prostate Cancer, Weight Loss Tea, Cell Cycle, Green Tea Nutrition, Resveratrol Supplements, Oncoguard System CapsuleRobert A. Wascher, MD, FACS 
Clinical Advisor & Oncology Consultant

Dr. Wascher is a noted surgical oncologist, cancer researcher, professor, and author. Dr. Wascher received his M.D. degree (magna cum laude) from the Creighton University School of Medicine.  Dr. Wascher’s research has focused on the detection of early cancer recurrence using molecular biology techniques, as well as in other areas of cancer biology, diagnosis, and treatment.  Dr. Wascher is also the author of the new comprehensive cancer prevention book, "A Cancer Prevention Guide for the Human Race," as well as the author of a widely read weekly global health information column (Weekly Health Update).


Selected Abstracts, Publications & Book Chapters by Dr. Wascher:

Crane-Okada R, Wascher R, Giuliano A.  Long-Term Morbidity of Sentinel Node Biopsy versus Complete Axillary Dissection for Unilateral Breast Cancer.  Ann Surg Oncol. 2008; 15:1996-2005.

Sabnani I, Varguese J, Wascher R, Youngworth H, Tsang P.  Multiple synchronous unusual extranodal sites of relapse in a patient with mantle cell lymphoma.  Clin Adv Hematol Oncol. 2007; 5:797-803.

Coviello LC, Wascher RA.  Hereditary neoplasia syndromes and the role of the surgeon.  Fam Cancer 2007; 2008;7:97-102.

Wascher RA, Rosenbaum EH, Andrews A, et al.:  Post-Breast Therapy Pain Syndrome in Rosenbaum EH, Spiegel D, Fobair P, Gautier H (eds.): Everyone’s Guide to Cancer Survivorship—A Road Map for Better Health.  Kansas City, Andrews McMeel Publishing, LLC, 2007, pp 169-172.

Takeuchi H, Wascher RA, Kuo C, Turner RR, Hoon DS.  Molecular diagnosis of micrometastasis in the sentinel lymph node.  Cancer Treat Res.  2005; 127:221-252.

Wascher RA.  Pitfalls in the Use of RT-PCR as a Prognostic Indicator in Melanoma. J Clin Oncol. 2005; 23:3863-3864.

Antedomenico E, Wascher RA.  A case of mistaken identity:  Giant cystic pheochromocytoma.  Curr Surg. 2005; 62:193-198.

Takeuchi H, Wascher RA, Kuo C, Turner RT, Hoon DS:  Molecular diagnosis of micrometastasis in the sentinel lymph node, in Leong SP, Kitagawa Y, Kitajima M (eds): Selective Sentinel Lymphadenectomy for Human Solid Cancer.  New York, NY, Springer Science+Business Media, Inc., 2005, pp 221-252. 

Wascher RA. The impact of Internet outreach on the wellbeing of postmastectomy breast cancer survivors. Proc of the Amer Soc Clin Oncol 2004.

Wascher RA, Morton DL, Gerami M, Kuo C, Elashoff RM, Wang HJ, Hoon DS.  Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with polyvalent melanoma cell vaccine.  J Clin Oncol. 2003; 21:2558-2563.

Wascher RA, Huynh KT, Giuliano AE, Hansen NM, Singer FR, Elashoff D, Hoon DS.  Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer.  Clin Cancer Res. 2003; 9:1427-1435.

Wascher RA: Overview of the sentinel lymph node concept.  Cancersupportivecare.com & Cancerlynx.com 2002.

Wascher RA: Postmastectomy pain syndromes: A surgeon’s perspective.  Cancersupportivecare.com & Cancerlynx.com 2002.

Wascher RA, Bostick PJ, Huynh KT, Turner R, Qi K, Giuliano AE, Hoon DS. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes. Br J Cancer 2001; 85:1340-1346.

Hoon DS, Kuo CT, Wascher RA, Fournier P, Wang HJ, O'Day SJ.  Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients. J Invest Dermatol 2001; 117:375-378.

Wascher RA, Lee M Y-T. Recurrent cutaneous leiomyosarcoma:  Case report and review of the literature. Cancer 1992; 70:490-2.

 

Bookmark and Share